TY - JOUR
T1 - History of cigarette smoking and risk of leukemia and myeloma
T2 - Results from the adventist health study
AU - Mills, Paul K.
AU - Newell, Guy R.
AU - Beeson, W. Lawrence
AU - Fraser, Gary E.
AU - Phillips, Roland L.
N1 - Funding Information:
Supported by Public Health Service grant CA-14703 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.
PY - 1990/5/5
Y1 - 1990/5/5
N2 - The risks of leukemia and myeloma associated with cigarette smoking were evaluated in a cohort study of 34,000 Seventh-day Adventists. Although Seventh-day Adventists do not smoke by church proscription, many are adult converts who smoked cigarettes prior to their baptism into the church. In comparison with those who never smoked, ex-smokers experience a relative risk of 2.00 (95% confidence interval = 1.01-3.95) for leukemia and 3.01 (95% confidence interval = 1.13-8.05) for myeloma. Risks increased in a doseresponse fashion with increasing numbers of cigarettes smoked daily for both leukemia (trend P =.005) and myeloma (trend P=.005). Also, the risks of both leukemia and myeloma increased with the total duration of cigarette smoking. The cigarette smokingleukemia relationship was strongest for myeloid leukemia, for which ex-smokers experienced a relative risk of 2.24 (95% confidence interval = 0.915.53). These data lend support to the hypothesis that cigarette smoke may induce malignant degeneration in bone marrow and its products. [J Natl Cancer Inst 82: 1832-1836, 1990].
AB - The risks of leukemia and myeloma associated with cigarette smoking were evaluated in a cohort study of 34,000 Seventh-day Adventists. Although Seventh-day Adventists do not smoke by church proscription, many are adult converts who smoked cigarettes prior to their baptism into the church. In comparison with those who never smoked, ex-smokers experience a relative risk of 2.00 (95% confidence interval = 1.01-3.95) for leukemia and 3.01 (95% confidence interval = 1.13-8.05) for myeloma. Risks increased in a doseresponse fashion with increasing numbers of cigarettes smoked daily for both leukemia (trend P =.005) and myeloma (trend P=.005). Also, the risks of both leukemia and myeloma increased with the total duration of cigarette smoking. The cigarette smokingleukemia relationship was strongest for myeloid leukemia, for which ex-smokers experienced a relative risk of 2.24 (95% confidence interval = 0.915.53). These data lend support to the hypothesis that cigarette smoke may induce malignant degeneration in bone marrow and its products. [J Natl Cancer Inst 82: 1832-1836, 1990].
UR - https://www.scopus.com/pages/publications/0025652975
UR - https://www.scopus.com/pages/publications/0025652975#tab=citedBy
U2 - 10.1093/jnci/82.23.1832
DO - 10.1093/jnci/82.23.1832
M3 - Article
C2 - 2250299
SN - 0027-8874
VL - 82
SP - 1832
EP - 1836
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 23
ER -